共 50 条
- [2] MACULAR ATROPHY AND MACULAR MORPHOLOGY IN AFLIBERCEPT-TREATED NEOVASCULAR AGE-RELATED MACULAR DEGENERATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (09): : 1743 - 1750
- [3] Macular translocation for neovascular age-related macular degeneration [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
- [6] Prevalence of neovascular age-related macular degeneration and geographic atrophy in Denmark [J]. DANISH MEDICAL JOURNAL, 2017, 64 (11):
- [7] Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration Efficacy and Macular Atrophy Development [J]. OPHTHALMOLOGY RETINA, 2018, 2 (05): : 462 - 468
- [8] Fundus Autofluorescence in Neovascular Age-Related Macular Degeneration: A Clinicopathologic Correlation Relevant to Macular Atrophy [J]. OPHTHALMOLOGY RETINA, 2021, 5 (11): : 1085 - 1096
- [9] Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
- [10] Ranibizumab for neovascular age-related macular degeneration [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431